<DOC>
	<DOCNO>NCT00131495</DOCNO>
	<brief_summary>This study design evaluate efficacy safety 2 dos transdermal testosterone patch naturally surgically menopausal woman low libido receive systemic estrogen estrogen progestin therapy .</brief_summary>
	<brief_title>Study Transdermal Testosterone Patches Menopausal Women With Low Libido</brief_title>
	<detailed_description>Detailed Description : Hypoactive sexual desire disorder ( HSDD ) condition suffer many 32 % menopausal population . It generally define low libido cause distress . Testosterone therapy ( transdermal patch ) currently investigation disorder result three phase 3 trial show evidence efficacy menopausal patient hormone replacement therapy . Low libido discriminate woman utilize hormone replacement therapy . This study design evaluate efficacy safety 2 dos transdermal testosterone patch naturally surgically menopausal woman low libido receive systemic estrogen estrogen progestin therapy . Persons could elect go single blind study one year complete first yeat double blind</detailed_description>
	<mesh_term>Sexual Dysfunctions , Psychological</mesh_term>
	<mesh_term>Testosterone</mesh_term>
	<mesh_term>Testosterone enanthate</mesh_term>
	<mesh_term>Testosterone undecanoate</mesh_term>
	<mesh_term>Testosterone 17 beta-cypionate</mesh_term>
	<mesh_term>Methyltestosterone</mesh_term>
	<criteria>Be generally healthy surgically menopausal woman ( 12 month ) , 20 70 year age , receive systemic estrogen estrogen progestin therapy Be generally healthy naturally menopausal woman ( 2 year since last period ) , 40 70 year age , receive systemic estrogen estrogen progestin therapy . Be , judgment , stable monogamous sexual relationship least one year prior study entry perceive secure communicative partner sexually functional physically present least 50 % time . Answer affirmatively ALL follow question : 1 . Was patient 's sex life menopause good satisfy general ? 2 . Since menopause , meaningful loss level desire sex occur ? 3 . Since menopause , significant decrease sexual activity occur ? 4 . Is current level desire interest sex bother concern ? 5 . Is increase level interest desire sex sexual activity desire ? Physical limitation would interfere normal sexual function ; Estrogen use last 12 week ( vaginal estriol low dose vaginal estradiol accept ) Use follow medication : antiandrogen therapy topical minoxidil ( last 5 year ) , androgen therapy ( past 3 months/implantable past 7 month ) , systemic corticosteroid , selective serotonin reuptake inhibitor ( SSRIs ) , tricyclic antidepressant , antiandrogens , systemic betablockers , antiadrenergics , spironolactone , apomorphine , phosphodiesterase type 5 ( PDE5 ) inhibitor ( e.g. , Viagra , tibolone selective estrogen receptor modulators ( SERMs ) , include tamoxifen ( last 12 week ) ) Be experience chronic acute life stress relate major life change may significantly interfere sexual function ; Have significant psychiatric disorder ( include mild depressive disorder Beck Depression InventoryII score &gt; 14 ; Have current severe dermatological problem know suspected hypersensitivity allergy adhesive constituent transdermal testosterone patch Have evidence history malignancy ( estrogen dependent gynecological cancer ) within last 5 year ; Have diabetes mellitus , active gallbladder disease , unstable thyroid disease , history cerebrovascular disease , thromboembolic disorder , myocardial infarction angina within last 5 year significant organic disease would prevent patient complete study , otherwise affect outcome study . Have significant abnormal pretreatment laboratory parameter .</criteria>
	<gender>Female</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>April 2013</verification_date>
	<keyword>Low Libido</keyword>
	<keyword>Low Desire</keyword>
	<keyword>Distress</keyword>
</DOC>